Research ExplorerPublicationsManagement and therapy of vasovagal syncope: A review

Management and therapy of vasovagal syncope: A review

Standard

Management and therapy of vasovagal syncope: A review. / Aydin, Muhammet Ali; Salukhe, Tushar V; Wilke, Iris; Willems, Stephan.

In: WORLD J CARDIOL, Vol. 2, No. 10, 26.10.2010, p. 308-315.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Aydin, MA, Salukhe, TV, Wilke, I & Willems, S 2010, 'Management and therapy of vasovagal syncope: A review', WORLD J CARDIOL, vol. 2, no. 10, pp. 308-315. https://doi.org/10.4330/wjc.v2.i10.308

APA

Aydin, M. A., Salukhe, T. V., Wilke, I., & Willems, S. (2010). Management and therapy of vasovagal syncope: A review. WORLD J CARDIOL, 2(10), 308-315. https://doi.org/10.4330/wjc.v2.i10.308

Vancouver

Aydin MA, Salukhe TV, Wilke I, Willems S. Management and therapy of vasovagal syncope: A review. WORLD J CARDIOL. 2010 Oct 26;2(10):308-315. https://doi.org/10.4330/wjc.v2.i10.308

Bibtex

@article{80773d01058d4b24b8f17999340b5cb4,
title = "Management and therapy of vasovagal syncope: A review",
abstract = "Vasovagal syncope is a common cause of recurrent syncope. Clinically, these episodes may present as an isolated event with an identifiable trigger, or manifest as a cluster of recurrent episodes warranting intensive evaluation. The mechanism of vasovagal syncope is incompletely understood. Diagnostic tools such as implantable loop recorders may facilitate the identification of patients with arrhythmia mimicking benign vasovagal syncope. This review focuses on the management of vasovagal syncope and discusses the non-pharmacological and pharmacological treatment options, especially the use of midodrine and selective serotonin reuptake inhibitors. The role of cardiac pacing may be meaningful for a subgroup of patients who manifest severe bradycardia or asystole but this still remains controversial.",
author = "Aydin, {Muhammet Ali} and Salukhe, {Tushar V} and Iris Wilke and Stephan Willems",
year = "2010",
month = oct,
day = "26",
doi = "10.4330/wjc.v2.i10.308",
language = "English",
volume = "2",
pages = "308--315",
journal = "WORLD J CARDIOL",
issn = "1949-8462",
publisher = "Baishideng Publishing Group Inc",
number = "10",

}

RIS

TY - JOUR

T1 - Management and therapy of vasovagal syncope: A review

AU - Aydin, Muhammet Ali

AU - Salukhe, Tushar V

AU - Wilke, Iris

AU - Willems, Stephan

PY - 2010/10/26

Y1 - 2010/10/26

N2 - Vasovagal syncope is a common cause of recurrent syncope. Clinically, these episodes may present as an isolated event with an identifiable trigger, or manifest as a cluster of recurrent episodes warranting intensive evaluation. The mechanism of vasovagal syncope is incompletely understood. Diagnostic tools such as implantable loop recorders may facilitate the identification of patients with arrhythmia mimicking benign vasovagal syncope. This review focuses on the management of vasovagal syncope and discusses the non-pharmacological and pharmacological treatment options, especially the use of midodrine and selective serotonin reuptake inhibitors. The role of cardiac pacing may be meaningful for a subgroup of patients who manifest severe bradycardia or asystole but this still remains controversial.

AB - Vasovagal syncope is a common cause of recurrent syncope. Clinically, these episodes may present as an isolated event with an identifiable trigger, or manifest as a cluster of recurrent episodes warranting intensive evaluation. The mechanism of vasovagal syncope is incompletely understood. Diagnostic tools such as implantable loop recorders may facilitate the identification of patients with arrhythmia mimicking benign vasovagal syncope. This review focuses on the management of vasovagal syncope and discusses the non-pharmacological and pharmacological treatment options, especially the use of midodrine and selective serotonin reuptake inhibitors. The role of cardiac pacing may be meaningful for a subgroup of patients who manifest severe bradycardia or asystole but this still remains controversial.

U2 - 10.4330/wjc.v2.i10.308

DO - 10.4330/wjc.v2.i10.308

M3 - SCORING: Journal article

C2 - 21160608

VL - 2

SP - 308

EP - 315

JO - WORLD J CARDIOL

JF - WORLD J CARDIOL

SN - 1949-8462

IS - 10

ER -